Fundz

Vedantra Pharmaceuticals, Inc. reported raising $750,000 in an initial SEC Form D filing, from an offering of $1.5 Million

PRIVATEMay 24, 2016$750K of $1.5M raised

Amount Raised

$750,000

$750,000 sold, per SEC Form D (first sale May 24, 2016)

Round Type

Seed

BostonBiotechnology

Who to call at Elicio Therapeutics, and when

A new round usually means Elicio Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Elicio Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Elicio Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Elicio Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Elicio Therapeutics

Location

ONE KENDALL SQUARE

Boston, Massachusetts, United States

About

Elicio Therapeutics is a clinical-stage biotechnology company developing a pipeline of novel immunotherapies for the treatment of cancer. By combining expertise in immunology and immunotherapy, Elicio is engineering investigational Amphiphile (“AMP”) immunotherapies intended to precisely target and fully engage the lymph nodes, the site in our bodies where the immune response is orchestrated. Elicio is engineering lymph node-targeted AMPlifiers, immunomodulators, adjuvants, and vaccines for an array of aggressive cancers.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Elicio Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsPeter D., Chief Scientific OfficerSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Elicio Therapeutics's next move

See what Strategic adds

Elicio Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.